로딩 중…
지수 로딩 중…
Kura Oncology, Inc.
KURA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$9.93+3.76%
2026-06-18
Price Chart
Kura Oncology, Inc.+63.86%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $882M |
| Revenue | $72M |
| Net Income | $-295M |
| Total Assets | $653M |
| Net Assets | $108M |
| Value | |
| P/B | 8.17x |
| P/S | 12.31x |
| FCF Yield | -9.58% |
| Profitability | |
| ROA | -45.14% |
| Op. Margin | -443.54% |
| Revenue Growth | 29.47% |
| Financial Health | |
| Debt Ratio | 504.87% |
| Total Debt | $24M |
| FCF | $-84M |
| Cash | $39M |
| Current Ratio | 6.15x |
| Performance | |
| 1Y Return | 63.86% |
| 1M Return | 10.83% |
| From 52W High | -20.50% |
| 1Y MDD | -39.04% |
| Trading | |
| Volume | 1,273,254 shares |
| Trading Value | $13M |
| Per Share | |
| EPS | $-3.16 |
| BPS | $1.98 |